EC: 7.6.2.1
P-type phospholipid transporter (ATP phosphohydrolase (P-type, phospholipid-flipping))
Pathways
| pathway id | name |
|---|---|
| Reactome:R-MMU-9029569 | LXRs regulate gene expression linked to cholesterol transport and efflux |
| Reactome:R-MMU-9024446 | LXR-mediated signaling |
| Reactome:R-HSA-9029569 | LXRs regulate gene expression linked to cholesterol transport and efflux |
| Reactome:R-HSA-9024446 | LXR-mediated signaling |
| Reactome:R-RNO-9748784 | Drug ADME |
| Reactome:R-MMU-9757110 | Prednisone ADME |
| Reactome:R-BTA-9709957 | Sensory Perception |
| Reactome:R-HSA-9709957 | Sensory Perception |
| Reactome:R-HSA-9757110 | Prednisone ADME |
| Reactome:R-MMU-9709957 | Sensory Perception |
| Reactome:R-MMU-9748784 | Drug ADME |
| Reactome:R-HSA-9748784 | Drug ADME |
| Reactome:R-RNO-9757110 | Prednisone ADME |
| Reactome:R-BTA-2453902 | The canonical retinoid cycle in rods (twilight vision) |
| Reactome:R-HSA-1369062 | ABC transporters in lipid homeostasis |
| Reactome:R-HSA-400206 | Regulation of lipid metabolism by PPARalpha |
| Reactome:R-HSA-2161517 | Abacavir transmembrane transport |
| Reactome:R-HSA-392499 | Metabolism of proteins |
| Reactome:R-MMU-1369062 | ABC transporters in lipid homeostasis |
| Reactome:R-MMU-162582 | Signaling Pathways |
| Reactome:R-MMU-2453902 | The canonical retinoid cycle in rods (twilight vision) |
| Reactome:R-RNO-5683826 | Surfactant metabolism |
| Reactome:R-RNO-382551 | Transport of small molecules |
| Reactome:R-BTA-2187338 | Visual phototransduction |
| Reactome:R-HSA-382556 | ABC-family proteins mediated transport |
| Reactome:R-HSA-8963898 | Plasma lipoprotein assembly |
| Reactome:R-HSA-556833 | Metabolism of lipids |
| Reactome:R-HSA-2161522 | Abacavir ADME |
| Reactome:R-HSA-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-MMU-382556 | ABC-family proteins mediated transport |
| Reactome:R-MMU-8963898 | Plasma lipoprotein assembly |
| Reactome:R-MMU-2187338 | Visual phototransduction |
| Reactome:R-RNO-392499 | Metabolism of proteins |
| Reactome:R-BTA-382551 | Transport of small molecules |
| Reactome:R-HSA-1989781 | PPARA activates gene expression |
| Reactome:R-HSA-2187338 | Visual phototransduction |
| Reactome:R-MMU-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-MMU-392499 | Metabolism of proteins |
| Reactome:R-MMU-5683826 | Surfactant metabolism |
| Reactome:R-RNO-382556 | ABC-family proteins mediated transport |
| Reactome:R-BTA-382556 | ABC-family proteins mediated transport |
| Reactome:R-HSA-382551 | Transport of small molecules |
| Reactome:R-HSA-174824 | Lipoprotein metabolism |
| Reactome:R-HSA-8963896 | HDL assembly |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-162582 | Signaling Pathways |
| Reactome:R-HSA-2453902 | The canonical retinoid cycle in rods (twilight vision) |
| Reactome:R-HSA-5683826 | Surfactant metabolism |
| Reactome:R-MMU-382551 | Transport of small molecules |
| Reactome:R-MMU-174824 | Lipoprotein metabolism |
| Reactome:R-MMU-8963896 | HDL assembly |
| Reactome:R-RNO-1369062 | ABC transporters in lipid homeostasis |
| WikiPathways:WP5176 | Disorders of bile acid synthesis and biliary transport |
| WikiPathways:WP5238 | Cholestasis |
| WikiPathways:WP5396 | Enterohepatic circulation of bile acids |
| PathBank:SMP0000435 | Docetaxel Action Pathway |
| PathBank:SMP0000439 | Vinorelbine Action Pathway |
| PathBank:SMP0000601 | Etoposide Metabolism Pathway |
| PathBank:SMP0000649 | Lamivudine Metabolism Pathway |
| PathBank:SMP0002425 | Lysolipid Incorporation into ER |
| PathBank:SMP0002492 | Lysolipid incorporation into Mitochondria PC(16:0/16:0) |
| PathBank:SMP0002515 | Lysolipid Incorporation into ER PC(16:1(9Z)/16:1(9Z)) |
| PathBank:SMP0002519 | Lysolipid Incorporation into ER PC(18:2(9Z,11Z)/18:2(9Z,11Z)) |
| PathBank:SMP0002523 | Lysolipid incorporation into Mitochondria PC(16:1(9Z)/16:1(9Z)) |
| PathBank:SMP0002527 | Lysolipid incorporation into Mitochondria PC(18:2(9Z,11Z)/18:2(9Z,11Z)) |
| PathBank:SMP0031694 | Imatinib Inhibition of BCR-ABL |
| PathBank:SMP0000434 | Paclitaxel Action Pathway |
| PathBank:SMP0000438 | Vindesine Action Pathway |
| PathBank:SMP0000472 | Erlotinib Action Pathway |
| PathBank:SMP0000600 | Irinotecan Metabolism Pathway |
| PathBank:SMP0000636 | Venlafaxine Metabolism Pathway |
| PathBank:SMP0000640 | Acetaminophen Metabolism Pathway |
| PathBank:SMP0000652 | Mycophenolic Acid Metabolism Pathway |
| PathBank:SMP0002424 | Lysolipid Incorporation into Mitochondria |
| PathBank:SMP0002514 | Lysolipid Incorporation into ER PC(16:0/16:0) |
| PathBank:SMP0002518 | Lysolipid Incorporation into ER PC(18:1(9Z)/18:1(9Z)) |
| PathBank:SMP0002522 | Lysolipid incorporation into Mitochondria PC(14:0/14:0) |
| PathBank:SMP0002526 | Lysolipid incorporation into Mitochondria PC(18:1(9Z)/18:1(9Z)) |
| PathBank:SMP0000436 | Vinblastine Action Pathway |
| PathBank:SMP0000442 | Etoposide Action Pathway |
| PathBank:SMP0000610 | Clopidogrel Metabolism Pathway |
| PathBank:SMP0000650 | Doxorubicin Metabolism Pathway |
| PathBank:SMP0002512 | Lysolipid Incorporation into ER PC(10:0/10:0) |
| PathBank:SMP0002516 | Lysolipid Incorporation into ER PC(16:1(11Z)/16:1(11Z)) |
| PathBank:SMP0002520 | Lysolipid Incorporation into ER PC(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) |
| PathBank:SMP0002524 | Lysolipid incorporation into Mitochondria PC(16:1(11Z)/16:1(11Z)) |
| PathBank:SMP0002528 | Lysolipid incorporation into Mitochondria PC(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) |
| PathBank:SMP0000433 | Irinotecan Action Pathway |
| PathBank:SMP0000437 | Vincristine Action Pathway |
| PathBank:SMP0000260 | Clopidogrel Action Pathway |
| PathBank:SMP0002513 | Lysolipid Incorporation into ER PC(14:0/14:0) |
| PathBank:SMP0002517 | Lysolipid Incorporation into ER PC(18:0/18:0) |
| PathBank:SMP0002521 | Lysolipid incorporation into Mitochondria PC(10:0/10:0) |
| PathBank:SMP0002525 | Lysolipid incorporation into Mitochondria PC(18:0/18:0) |